Kura Oncology, Inc. (KURA)

NMS – Real Time Price. Currency in USD

9.86

-0.07 (-0.65%)

Market open: Aug 12, 2026, 2:04 PM EDT

9.96

+0.03 (0.34%)

Previous after-hours: Aug 11, 2026, 7:54 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

67M

54M

Cost of goods sold

-1M

-848K

-849K

-759K

Gross Profit

66M

53M

-849K

-759K

Operating expenses (excl. COGS)

-370M

-246M

-165M

-139M

Operating Income

-304M

-193M

-166M

-140M

Non-operating income, total

25M

21M

13M

Pretax income

-278M

-172M

-153M

-136M

Equity in earnings

Taxes

-297K

-2M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-279M

-174M

-153M

-136M

Discontinued operations

Net income

-279M

-174M

-153M

-136M

Dilution adjustment

Preferred dividends

Kura Oncology, Inc. (KURA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Kura Oncology, Inc. (KURA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Kura Oncology, Inc. (KURA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Kura Oncology, Inc. (KURA)

Income Statement (Annual)

Income Statement (Annual)